Student health-care workers with cystic fibrosis: a review of recommendations for students on clinical placement
Lyn-Li Lim A C , Cristina Mateevici A and Mary O’Reilly A B
+ Author Affiliations
- Author Affiliations
A Infectious Diseases Unit, Eastern Health, PO Box 94, Box Hill, Vic. 3128, Australia.
B Monash University, Eastern Clinical School, 5 Arnold Street, Box Hill, Vic. 3128, Australia.
C Corresponding author. Email: lyn-li.lim@easternhealth.org.au
Healthcare Infection 17(3) 77-82 https://doi.org/10.1071/HI12014
Submitted: 23 April 2012 Accepted: 14 June 2012 Published: 16 July 2012
Abstract
Student health-care workers (sHCW) with cystic fibrosis (CF) on clinical placement pose unique infection control issues, with potential acquisition and transmission of multi-resistant pathogens between sHCW and patients. We reviewed existing Australian infectious diseases policies and guidelines for sHCW and published data on the potential infection control risks posed by sHCW with CF in this setting. Current consensus infectious diseases guidelines for sHCW address blood-borne viruses but do not address CF, and the management of sHCW with CF is controversial. While the potential risk of nosocomial transmission of multi-resistant organisms such as Pseudomonas aeruginosa and Staphylococcus aureus, both to and from sHCW with CF is acknowledged, there have been no reports of HCW with CF-linked with outbreaks. Given the recognised risk, sHCW with CF will more than likely require modifications to their learning programs while on clinical placement to allow them to complete their studies and adequately prepare them for a range of practice in their chosen profession, while minimising risk to both patients and themselves. Universities organising clinical placement for sHCW with CF are obliged to provide vocational and academic counselling as early into the course as possible. Limited disclosure of the status of the sHCW with CF to direct clinical supervisors and infection control is essential in order to observe duty of care towards the student as well as ensuring the safety of the patients.
References
[1] Cystic Fibrosis in Australia. Data registry. North Ryde, NSW: Cystic Fibrosis Australia; 2012. Available online at: http://www.cysticfibrosis.org.au/projects/dataregistry/ [verified 17 January 2012][2] Cystic Fibrosis in Australia. The standards of cystic fibrosis care guidelines. North Ryde, NSW: Cystic Fibrosis Australia; 2012. Available online at: http://www.cysticfibrosis.org.au/projects/standardsofcare/ [verified 17 January 2012]
[3] Walters S. Health service careers for people with cystic fibrosis. J R Soc Med 2002; 95 41–51.
[4] Saiman L, Siegel J. Infection control in cystic fibrosis. Clin Microbiol Rev 2004; 17 57–71.
| Infection control in cystic fibrosis.Crossref | GoogleScholarGoogle Scholar |
[5] Donaldson SH, Wolfgang MC, Gilligan PH, Boucher RC. Cystic fibrosis. In: Mandell G, Bennett J, Dolin R, eds. Principles and Practice of Infectious Diseases. 7th edn. Philadelphia: Churchill Livingstone Elsevier; 2010.
[6] Jonwa AM, Govan JR, Doherty CJ, Dodd ME, Isalska BJ, Stanbridge TN, et al Spread of multi-resistant strain of Pseudomomnas aeruginosa in an adult cystic fiobrosis clinic. Lancet 2001; 358 557–8.
[7] Armstrong DS, Nixon GM, Carzino R, Bigham A, Carlin JB, Robins-Brown RM, et al Detection of a wide-spread clone of Pseudomonas aeruginosa in a paediatric cystic fibrosis clinic. Am J Resp Crit Care Med 2002; 166 983–7.
| Detection of a wide-spread clone of Pseudomonas aeruginosa in a paediatric cystic fibrosis clinic.Crossref | GoogleScholarGoogle Scholar |
[8] Tummler B, Koopmann U, Grothues D, Weissbrodt GH, Steinkamp G, von der Hardt H. Nosocomial acquisition of Pseudomonas aeruginosa by cystic fibrosis patients. J Clin Microbiol 1991; 29 1265–7.
| 1:STN:280:DyaK3MzisVCmug%3D%3D&md5=a0ceafe13c12c01b38646fc9673ff7edCAS |
[9] Festini F, Buzzetti R, Bassi C, Braggion C, Salvatore D, Tacetti G, et al Isolation measures for the prevention of infection with respiratory pathogens in cystic fibrosis: a systematic review. J Hosp Infect 2006; 64 1–6.
| Isolation measures for the prevention of infection with respiratory pathogens in cystic fibrosis: a systematic review.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DC%2BD28vnvVSqtQ%3D%3D&md5=ed32d6eaa44cc8fbce0461e51c27cc89CAS |
[10] Conway S. Segregation is good for patients with cystic fibrosis. J R Soc Med 2008; 101 31–5.
| Segregation is good for patients with cystic fibrosis.Crossref | GoogleScholarGoogle Scholar |
[11] Dasenbrook EC, Merlo CA, Diener-West M, Lechtzin N, Boyle MP. Persistent methicillin-resistant Staphylococcus aureus and rate of FEV1 decline in cystic fibrosis. Am J Respir Crit Care Med 2008; 178 814–21.
| Persistent methicillin-resistant Staphylococcus aureus and rate of FEV1 decline in cystic fibrosis.Crossref | GoogleScholarGoogle Scholar |
[12] Dasenbrook EC, Checkley W, Merlo CA, Konstan MW, Lechtzin N, Boyle MP. Association between respiratory tract methicillin-resistant Staphylococcus aureus and survival in cystic fibrosis. JAMA 2010; 303 2386–92.
| Association between respiratory tract methicillin-resistant Staphylococcus aureus and survival in cystic fibrosis.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC3cXnslGqur4%3D&md5=363b85e53850a295a686bb2f4a0a1292CAS |
[13] Blok HE, Troelstra A, Kamp-Hopmans TE, Gigengack-Baars AC, Vandenbroucke-Grauls JE, Weersink AJ, et al Role of healthcare workers in outbreaks of methicilllin-resistant Staphylococcus aureus: a 10-year evaluation from a Dutch university hospital. Infect Control Hosp Epidemiol 2003; 24 679–85.
| Role of healthcare workers in outbreaks of methicilllin-resistant Staphylococcus aureus: a 10-year evaluation from a Dutch university hospital.Crossref | GoogleScholarGoogle Scholar |
[14] Vonberg RP, Stamm-Baldejahn S, Hansen S, Zuschneid I, Ruden H, Behnke M, et al How often do asymptomatic health care workers cause methicillin-resistant Staphylococcus aureus outbreaks? A systematic evaluation. Infect Control Hosp Epidemiol 2006; 27 1123–7.
| How often do asymptomatic health care workers cause methicillin-resistant Staphylococcus aureus outbreaks? A systematic evaluation.Crossref | GoogleScholarGoogle Scholar |
[15] Mean M, Mallaret MR, Andrini P, Recule C, Debillon T, Pavese P, Croize J.. A neonatal specialist with recurrent methicillin-resistant Staphylococcus aureus (MRSA) carriage implicated in the transmission of MRSA to newborns. Infect Control Hosp Epidemiol 2007; 28 625–8.
| A neonatal specialist with recurrent methicillin-resistant Staphylococcus aureus (MRSA) carriage implicated in the transmission of MRSA to newborns.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DC%2BD2s3lsFWjtQ%3D%3D&md5=00e63925cdb5ced13947eaa5646cf17dCAS |
[16] Moolenaar RL, Crutcher M, San Joaquin VH, Sewell LV, Hutwagner LC, Carson LA. A prolonged outbreak of Pseudomonas aeruginosa in a neonatal intensive care unit: did staff fingernails play a role in disease transmission? Infect Control Hosp Epidemiol 2000; 21 80–5.
| A prolonged outbreak of Pseudomonas aeruginosa in a neonatal intensive care unit: did staff fingernails play a role in disease transmission?Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DC%2BD3c7mtVemtw%3D%3D&md5=d5faa58a5ba9c3727cca823e97850cadCAS |
[17] Trick WE, Kioski CM, Howard KM, Cage GD, Tokars JI, Yen BM, et al Outbreak of Pseudomonas aeruginosa ventriculitis among patients in a neurosurgical intensive care unit. Infect Control Hosp Epidemiol 2000; 21 204–8.
| Outbreak of Pseudomonas aeruginosa ventriculitis among patients in a neurosurgical intensive care unit.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DC%2BD3c3gtFGksg%3D%3D&md5=c2d6fe5d9f39682c64c0ab483476b9c3CAS |
[18] Boyce JM. Spread of methicillin-resistant Staphylococcus aureus in a hospital after exposure to a health care worker with chronic sinusitis. Clin Infect Dis 1993; 17 496–504.
| Spread of methicillin-resistant Staphylococcus aureus in a hospital after exposure to a health care worker with chronic sinusitis.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DyaK2c%2Fjt1yksQ%3D%3D&md5=ed057f242b41502af0d6f57763aaab84CAS |
[19] Ben-David D, Mermel LA, Parenteau S. Methicillin-resistant Staphylococcus aureus transmission: the possible importance of unrecognized health care worker carriage. Am J Infect Control 2008; 36 93–7.
| Methicillin-resistant Staphylococcus aureus transmission: the possible importance of unrecognized health care worker carriage.Crossref | GoogleScholarGoogle Scholar |
[20] Meier PA, Carter CD, Wallace SE, Hollis RJ, Pfaller MA, Herwaldt LA. A prolonged outbreak of methicillin-resistant Staphylococcus aureus in the burn unit of a tertiary medical center. Infect Control Hosp Epidemiol 1996; 17 798–802.
| A prolonged outbreak of methicillin-resistant Staphylococcus aureus in the burn unit of a tertiary medical center.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DyaK2s7jvVOmtA%3D%3D&md5=466db76f825c64a19251dc237504ceacCAS |
[21] Lessing MP, Jordens JZ, Bowler IC. When should healthcare workers be screened for methicillin-resistant Staphylococcus aureus? J Hosp Infect 1996; 34 205–10.
| When should healthcare workers be screened for methicillin-resistant Staphylococcus aureus? Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DyaK2s%2Fot1SgsA%3D%3D&md5=dd06dab5634c236ce233dcfa095fc665CAS |
[22] Siegel JD, Rhinehart E, Jackson M, Chiarello L. 2007 guideline for isolation precautions: preventing transmission of infectious agents in health care settings. Available online at: http://www.cdc.gov/hicpac/2007IP/2007isolationPrecautions.html [verified 17 January 2012]
[23] Wainwright CE, France MW, O’Rourke P, Anuj S, Kidd TJ, Nissen MD, et al Cough-generated aerosols of Pseudominas aeruginosa and other Gram-negative bacteria from patients with cystic fibrosis. Thorax 2009; 64 926–31.
| Cough-generated aerosols of Pseudominas aeruginosa and other Gram-negative bacteria from patients with cystic fibrosis.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DC%2BD1MjitFWqsg%3D%3D&md5=bee484ac362581e73185edaf966894b9CAS |
[24] Hand Hygiene Australia. National data period 1, 2012. Available online at: http://www.hha.org.au/LatestNationalData.aspx [verified 17 January 2012]
[25] Cystic Fibrosis in Australia. Infection control guidelines for cystic fibrosis patients and carers. North Ryde, NSW: Cystic Fibrosis Australia; 2012. http://www.cysticfibrosis.org.au/pdf/Handbook-Infection_Control.pdf [verified 17 January 2012]
[26] Mahenthiralingam E, Vandamme P, Campbell ME, Henry DA, Gravelle AM, Wong LT, et al Infection with Burkholderia cepacia Complex Genomovars in Patients with Cystic Fibrosis:Virulent Transmissible Strains of Genomovar III Can Replace Burkholderia multivorans. Clin Infect Dis 2001; 33 1469–75.
| Infection with Burkholderia cepacia Complex Genomovars in Patients with Cystic Fibrosis:Virulent Transmissible Strains of Genomovar III Can Replace Burkholderia multivorans.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DC%2BD3MrktFWnsg%3D%3D&md5=00a825660bef36cc8b7527c410a15b3dCAS |
[27] Ojeniyi B, Peterson US, Hoiby N. Comparison of genome fingerprinting with conventional typing methods used on Pseudomonas aeruginosa isolates from cystic fibrosis patients. APMIS 1993; 101 168–75.
| Comparison of genome fingerprinting with conventional typing methods used on Pseudomonas aeruginosa isolates from cystic fibrosis patients.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DyaK3s3lslWgtg%3D%3D&md5=000e047382f2e16f9685edded58220a0CAS |
[28] Romling U, Fiedler B, Bosshammer D, Grothues D, Greipel J, von der Hardt H, et al Epidemiology of chronic Pseudomonas aeruginosa infections in cystic fibrosis. J Infect Dis 1994; 170 1616–21.
| Epidemiology of chronic Pseudomonas aeruginosa infections in cystic fibrosis.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DyaK2M%2FovVCmsA%3D%3D&md5=c52f357ff7da7a2322b568abd49e14c9CAS |
[29] Wolz C, Kiosz G, Ogle JW, Vasil ML, Schaad U, Botzenhart K, et al Pseudomonas aeruginosa cross colonization and ppersistence in patients with cystic fibrosis. Epidemiol Infect 1989; 102 205–14.
| Pseudomonas aeruginosa cross colonization and ppersistence in patients with cystic fibrosis.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DyaL1M7ps1Gmug%3D%3D&md5=79dac27492c9748554eb4029e63c20d0CAS |
[30] Downey DG, Kidd TJ, Coulter C, Bell SC. MRSA eradication in a health care worker with cystic fibrosis: re-emergence or re-infection? J Cyst Fibros 2005; 4 205–7.
| MRSA eradication in a health care worker with cystic fibrosis: re-emergence or re-infection?Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DC%2BD2Mvmt1ejtQ%3D%3D&md5=0cba1a760451b3642147f6dcfa0b41d8CAS |
[31] Ratjen F, Munck A, Kho P, Angyalosi G, ELITE study group Treatment of early Pseudomonas aeruginosa infection in patients with cystic fibrosis: the ELITE trial. Thorax 2010; 65 286–91.
| Treatment of early Pseudomonas aeruginosa infection in patients with cystic fibrosis: the ELITE trial.Crossref | GoogleScholarGoogle Scholar |
[32] Treggiari MM, Retsch-Bogart G, Mayer-Hamblett N, Khan U, Kulich M, Kronmal R, et al EPIC study group. Arch Pediatr Adolesc Med 2011; 165 847–56.
| EPIC study group.Crossref | GoogleScholarGoogle Scholar |
[33] Keen EF, Robinson BJ, Hospenthal DR, Aldous WK, Wolf SE, Chung KK, et al Incidence and bacteriology of burn infections at a military burn centre. Burns 2010; 36 461–8.
| Incidence and bacteriology of burn infections at a military burn centre.Crossref | GoogleScholarGoogle Scholar |
[34] Groll AH, Tragiannidis A. Recent advances in antifungal prevention and treatment. Semin Hematol 2009; 46 212–29.
| Recent advances in antifungal prevention and treatment.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BD1MXovFaru70%3D&md5=6dc4f99532548dc81216dfb38734ec56CAS |
[35] Maschmeyer G, Neuburger S, Maschmeyer G, Fritz L, Böhme A, Penack O, et al A prospective randomised study on the use of well-fitting masks for the prevention of invasive aspergillosis in high-risk patients. Ann Oncol 2009; 20 1560–4.
| A prospective randomised study on the use of well-fitting masks for the prevention of invasive aspergillosis in high-risk patients.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DC%2BD1MrnsVClsQ%3D%3D&md5=bc3af98735fa4ac8c3b0085f56878c65CAS |
[36] Pakyz AL, Farr BM. Rates of Sternotrophomonas maltophilia colonization and infection in relation to antibiotic cycling protocols. Epidemiol Infect 2009; 137 1679–83.
| Rates of Sternotrophomonas maltophilia colonization and infection in relation to antibiotic cycling protocols.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DC%2BD1MjisFOnuw%3D%3D&md5=daee2a2a5b0b83f2e61edd9d2a5bd230CAS |
[37] Rangel EL, Butler KL, Johannigman JA, Tsuei BJ, Solomkin JS. Risk factors for the relapse of ventilator-associated pneumonia in trauma patients. J Trauma 2009; 67 91–6.
| Risk factors for the relapse of ventilator-associated pneumonia in trauma patients.Crossref | GoogleScholarGoogle Scholar |
[38] Jones P, Brown D. Guidelines for infectious diseases policies and programs for medical students. 2001. Available online at: http://www.medicaldeans.org.au/wp-content/uploads/Infectious-Disease-Policy.pdf [verified 17 January 2012]